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Ageing is a multifactorial process associated with multiple mechanisms, some of which 
include telomere shortening, changes in metabolism associated with disrupted 
mitochondrial dynamics, stem cell exhaustion and cellular senescence or 
inflammation. Despite differences in physiological changes between different tissues, 
a set of unifying hallmarks of ageing has been defined providing a framework for 
understanding the process of ageing at cellular and organismal level. Given the 
complexity of the ageing process, the underlying mechanisms are still not well 
understood.  The advent of –omics level technologies is now allowing a window on the 
molecular etiology of the ageing process, and how it contributes to age-related 
disease. New high throughput deep reach technologies now exist to query changes in 
ageing cells and populations at the level of the epigenome, the transcriptome, the 
proteome, the metabolome and the microbiome. These approaches are suitable for 
both hypothesis free discovery science, but also for detailed molecular 
characterization of specific phenotypes. Integration of these datasets represents a 
challenge but also an opportunity for reaching a deeper understanding of the 
molecular causes and consequences of ageing. 
 
In this special issue, Frenk & Houseley (2018) discuss the challenges of investigating 
molecular basis of ageing. The authors identify gene expression hallmarks of ageing 
and ask: is ageing a programmed process, is it conserved among species, do different 
tissues age at the same rate? Continuing the topic of biomarkers of ageing, the review 
by Pawelec (2017) offers an insight into a set of parameters characterizing ageing: 
“immune Risk Profile”, IRP, a cluster of simple baseline immune parameters 
associated with excess mortality in older people, and discusses how IRPs are context-
dependent. On the other hand, “immunosenescence”, can be itself considered a 
hallmark of ageing. Ageing-associated remodelling of the immune system has 
significant impact on health of older people. Duggal et al. (2018) summarise our 
current understanding of immunesenescence and discuss lifestyle and 
pharmacological interventions shown to restore immune functioning in aged 
individuals. Lorenzo et al. (2018), offer further insight into the consequences of ageing 
on immune system, focusing on CD4+ T cell differentiation and function, linked to 
susceptibility of older people to infections, such as influenza.  
Cellular senescence, not restricted to immunosenescence, is considered one of the 
key mechanisms underlying ageing. Accumulating senescent cells can contribute to 
disease progression not only through their changed function but also through affecting 
the surrounding environment. Burton & Faragher (2018) examine the underlying 
conceptual mechanisms by which senescent cells could contribute to a tissue 
functional decline and elegantly demonstrate that senescent cells are more than 
“simply irreversible proliferative arrest”. The authors further discuss therapeutic 
targeting senescent cells for delaying age-related diseases, such as type-2 diabetes 
or metabolic syndrome. Lopez-Llunch (2018) further explores age-related diseases by 
focusing on mitochondrial dynamics. Mitochondria, the cells’ powerhouses, are key 
organelles associated with metabolism and “mitochondrial theory” describes the 
efficiency of mitochondrial activity as key for longevity and ageing. Lopez-Lunch 
discusses interventions, such as caloric restriction, aiming at maintenance of 
bioenergetics homeostasis to delay ageing and prevent age-related diseases, such as 
sarcopenia. The current studies on mechanisms of sarcopenia and potential 
interventions to prevent or delay age-related loss of muscle mass and function, with 
focus on personalized approaches in conjunction with pharmacological interventions 
are further described in this issue by McCormick & Vasilaki (2018).  
Changes in the number and/or functionality of stem cells have also been shown to 
contribute to age-related disorders. Adult stem cells are also used to target many 
changes that negatively impact tissue fitness with age. Rogers et al. (2018)discuss 
the role of circadian clocks in adult stem cell maintenance and how they control stem 
cell function. The topic of therapeutics is continued by Bikkul’s article which focuses 
on a rare premature ageing disease: Hutchinson-Gilford Progeria Syndrome (HGPS) 
and drug treatments and regimes currently used in clinical trials (Bikkul et al. 2018). 
Finally, the review by Ezcurra (2018) discusses a new exciting research area in the 
field of ageing: how the human microbiome can change in specific disease states. 
However, it remains to be established if there is a causal link between microbial 
variation, disease and ageing.  
 
In summary, this special issue brings together state-of-the-art thinking on the 
molecular causes and consequences of ageing, which may herald the development of 
an entirely new generation of anti-degenerative therapies. These may encompass 
modifiers of chromatin biology, regulators of mRNA processing, interventions to 
moderate mitochondrial number or function, interventions to address or repair DNA 
damage or tools to influence the metabolome, the proteome or the microbiome. Huge 
increases in our molecular toolkit have allowed insights into ageing processes that 
were previously impossible. We now face a challenge in  translating these findings into 
meaningful advances in our understanding of the ageing process, and in translating 
them to the clinic. 
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